12188 T/C 0.5 0.2% 0.2%
Validation by ARMS-qPCR in PF
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Shared mutations 10 BiPSC
Heteroplasmy (%)
Heteroplasmy ( Sheet 1, 72-year-old A subject; sheet 2, 60-year-old subject; sheet 3, 28-year-old subject. Sheet 1, 72-year-old A subject; sheet 2, 72-year-old B subject; sheet 3, 67-year-old A subject; sheet 4, 67-year-old B subject; sheet 5, 67-year-old B subject; sheet 6, 50-year-old subject; sheet 7, 33-year-old subject; sheet 8, 28-year-old subject; sheet 9, 27-year-old subject; sheet 10, 24-year-old subject; sheet 11, 30-year-old subject. Sheet 1, 72-year-old B subject; sheet 2, 67-year-old subject; sheet 3, 66-year-old subject. Percentages of blastocyst formation were based on the numbers of MII oocytes used. Percentages of ESC line establishment were based on the numbers of blastocysts. Heteroplasmy levels for most mutations remained stable between iPSCs and their differentiated fibroblasts.
SUPPLEMENTAL TABLES
FiPSC were expanded to passage 12 and then differentiated to fibroblasts. Fibroblasts were cultured for additional 1-3 passages before analysis.
